All these antidiabetic treatment options have been shown to be capable of reaching a good glycemic target, so that therapy nowadays can be individualized and chosen according to patients risk factors, HbA1C levels, formulation and ease of use, costs, and potential side effects
In the matched cohort, which controlled for potential confounding factors, GLP-1 use was associated with a 30.5% reduction in breast cancer incidence
Mitochondria are both sources and targets of ROS in diabetic conditions
This hypothetical situation might explain why patients with higher plasma 5HT concentrations responded better to SSRIs
You're on GLP-1s or want to track what's working Adding a blend to a protocol with Retatrutide, Tirzepatide, or other active compounds makes it hard to attribute effects
We know you cant always slip away during lunch for a medical appointment